Maurice Bloch
University of British Columbia
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Maurice Bloch.
The New England Journal of Medicine | 1992
Sandi Wiggins; Patti Whyte; Marlene Huggins; Shelin Adam; Jane Theilmann; Maurice Bloch; Samuel B. Sheps; Martin T. Schechter; Michael R. Hayden
Abstract Background. Advances in molecular genetics have led to the development of tests that can predict the risk of inheriting the genes for several adult-onset diseases. However, the psychological consequences of such testing are not well understood. Methods. The 135 participants in the Canadian program of genetic testing to predict the risk of Huntingtons disease were followed prospectively in three groups according to their test results: the increased-risk group (37 participants), the decreased-risk group (58 participants), and the group with no change in risk (the no-change group) (40 participants). All the participants received counseling before and after testing. Standard measures of psychological distress (the General Severity Index of the Symptom Check List 90-R), depression (the Beck Depression Inventory), and well-being (the General Well-Being Scale) were administered before genetic testing and again at intervals of 7 to 10 days, 6 months, and 12 months after the participants received their t...
American Journal of Human Genetics | 1999
Elisabeth W. Almqvist; Maurice Bloch; Ryan R. Brinkman; David Craufurd; Michael R. Hayden
Prior to the implementation of predictive-testing programs for Huntington disease (HD), significant concern was raised concerning the likelihood of catastrophic events (CEs), particularly in those persons receiving an increased-risk result. We have investigated the frequency of CEs-that is, suicide, suicide attempt, and psychiatric hospitalization-after an HD predictive-testing result, through questionnaires sent to predictive-testing centers worldwide. A total of 44 persons (0.97%) in a cohort of 4,527 test participants had a CE: 5 successful suicides, 21 suicide attempts, and 18 hospitalizations for psychiatric reasons. All persons committing suicide had signs of HD, whereas 11 (52.4%) of 21 persons attempting suicide and 8 (44.4%) of 18 who had a psychiatric hospitalization were symptomatic. A total of 11 (84.6%) of 13 asymptomatic persons who experienced a CE during the first year after HD predictive testing received an increased-risk result. Factors associated with an increased risk of a CE included (a) a psychiatric history </=5 years prior to testing and (b) unemployed status. The frequency of CEs did not differ between those persons receiving results of predictive testing through linkage analysis in whom there was only changes in direction of risk and those persons receiving definitive results after analysis for the mutation underlying HD. These findings provide insights into the frequency, associated factors, and timing of CEs in a worldwide cohort of persons receiving predictive-testing results and, as such, highlight persons for whom ongoing support may be beneficial.
Electroencephalography and Clinical Neurophysiology | 1989
Andrew Eisen; Saeed Bohlega; Maurice Bloch; Michael R. Hayden
Short-latency (R1) and long-latency (R2) components of the stretch reflex, the electromyographic silent period (S-X interval) and motor evoked potentials (MEPs) elicited by magnetic stimulation of the cortex were measured in Huntingtons disease (HD), at-risk first degree relatives and a normal control group. R1 and MEPs as well as central motor delay were normal in all 3 groups. R2 was absent in 7/9 patients with HD and 3/13 at-risk subjects. The S-X interval was reduced (less than 84 msec) in 7/9 patients and 5/13 at-risk subjects. Combined studies were abnormal in 88.9% of patients and 54% of at-risk subjects.
The Lancet | 1987
MichaelR. Hayden; JohnJ.P. Kastelein; R. Douglas Wilson; Chantal Hilbert; Jeffrey Hewitt; Sylvie Langlois; Sharon Fox; Maurice Bloch
Polymorphic DNA probes linked to the locus for Huntington disease (HD) were used for prenatal diagnosis of a 10-week fetus at 25% risk for the disease. The fetus proved to have a 48% risk of having inherited the HD mutation which was similar to that for the at-risk parent (50%). On this basis the parents elected to terminate the pregnancy. When appropriate family members are available and DNA studies are informative, prenatal diagnosis of HD with polymorphic DNA probes can determine the at-risk status of the fetus with 96% accuracy.
American Journal of Human Genetics | 1997
Elisabeth W. Almqvist; Shelin Adam; Maurice Bloch; Anne Fuller; Philip Welch; Debbie Eisenberg; Don Whelan; David Macgregor; Wendy S. Meschino; Michael R. Hayden
The first predictive testing for Huntington disease (HD) was based on analysis of linked polymorphic DNA markers to estimate the likelihood of inheriting the mutation for HD. Limits to accuracy included recombination between the DNA markers and the mutation, pedigree structure, and whether DNA samples were available from family members. With direct tests for the HD mutation, we have assessed the accuracy of results obtained by linkage approaches when requested to do so by the test individuals. For six such individuals, there was significant disparity between the tests. Three went from a decreased risk to an increased risk, while in another three the risk was decreased. Knowledge of the potential reasons for these changes in results and impact of these risk reversals on both patients and the counseling team can assist in the development of strategies for the prevention and, where necessary, management of a risk reversal in any predictive testing program.
Obstetrical & Gynecological Survey | 1993
Sandi Wiggins; Path Whyte; Marlene Huggins; Shelin Adam; Jane Theilmann; Maurice Bloch; Samuel B. Sheps; Martin T. Schechter; Michael R. Hayden
BACKGROUND Advances in molecular genetics have led to the development of tests that can predict the risk of inheriting the genes for several adult-onset diseases. However, the psychological consequences of such testing are not well understood. METHODS The 135 participants in the Canadian program of genetic testing to predict the risk of Huntingtons disease were followed prospectively in three groups according to their test results: the increased-risk group (37 participants), the decreased-risk group (58 participants), and the group with no change in risk (the no-change group) (40 participants). All the participants received counseling before and after testing. Standard measures of psychological distress (the General Severity Index of the Symptom Check List 90-R), depression (the Beck Depression Inventory), and well-being (the General Well-Being Scale) were administered before genetic testing and again at intervals of 7 to 10 days, 6 months, and 12 months after the participants received their test results. RESULTS At each follow-up assessment, the decreased-risk group had lower scores for distress than before testing (P < 0.001). The increased-risk group showed no significant change from base line on any follow-up measure, but over the year of study there were small linear declines (P < 0.023) for distress and depression. The no-change group had scores lower than at base line on the index of general well-being at each follow-up (P < or = 0.045). At the 12-month follow-up, both the increased-risk group and the decreased-risk group had lower scores for depression and higher scores for well-being than the no-change group (P < or = 0.049). CONCLUSIONS Predictive testing for Huntingtons disease has potential benefits for the psychological health of persons who receive results that indicate either an increase or a decrease in the risk of inheriting the gene for the disease.
American Journal of Medical Genetics | 1992
Marlene Huggins; Maurice Bloch; Sandi Wiggins; Shelin Adam; Oksana Suchowersky; Michael Trew; Marylou Klimek; Cheryl R. Greenberg; Michael K. Eleff; Louise P. Thompson; Julie Knight; Patrick MacLeod; Kathleen Girard; Jane Theilmann; Amy Hedrick; Michael R. Hayden
American Journal of Medical Genetics | 1992
Maurice Bloch; Shelin Adam; Sandy Wiggins; Marlene Huggins; Michael R. Hayden
American Journal of Medical Genetics | 1989
Maurice Bloch; M. Fahy; S. Fox; Michael R. Hayden; James F. Reynolds
American Journal of Human Genetics | 1990
Maurice Bloch; Michael R. Hayden